Drug Research
Shoreline Launches into Era of Cell Therapy with $4 Billion in Partnerships
Shoreline Biosciences, an immunotherapy company formed in 2020 during the early days of the COVID-19 pandemic, was propelled into the proverbial catbird’s seat this...
Drug Research
Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
Abveris, Inc., and Abilita Bio, Inc., both privately held biotechnology companies, announce a joint research collaboration that will leverage the synergies between their platforms...
Drug Research
India’s first mRNA Covid vaccine by Gennova granted approval for Phase 2/3 clinical trails
India’s first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trials, the Department of Biotechnology...
News
Sorrento’s Covid-19 vaccine induces robust immune responses in studies
Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19. The publication details preclinical vaccination...
News
US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction
Jardiance® (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for...
Drug Research
Genevant Sciences Announces Global Collaboration with Takeda to Develop Novel Nonviral Gene Therapies for Up to Two Rare Liver Diseases
Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, announced...
News
DKSH Selected as Medigen’s COVID-19 Vaccine Distribution Partner in Taiwan
DKSH Business Unit Healthcare has entered into a partnership with Medigen Vaccine Biologics Corporation to ensure that their COVID-19 vaccines are speedily delivered and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read